News
Using GLP-1 drugs for weight loss is considered safe but can come with a loss of lean muscle mass. It’s crucial to do ...
Shares in Danish pharma company Novo Nordisk jumped after it halved the out-of-pocket price of Ozempic in the US and gained ...
Lilly to raise UK Mounjaro price 170% from £122 to £330 monthly amid White House push for European drug price increases to ...
24m
Press Trust of India on MSNKitaab launch of book 'The Weight Loss Revolution' shares scientific strategies to combat obesity and weight loss
Neelima Dalmia, Shivam Vij, Shobhana Bhartia, Dr Jitendra Singh, Sharmila Tagore, Dr Ambrish Mithal, Bharti Modhak and Vir Sanghvi at the Kitaab book launch Kolkata (West Bengal) [India], August 18: ...
42m
Baller Alert on MSNOzempic and Zepbound Lawsuits Explode: Patients Say Popular Weight-Loss Drugs Left Them Hospitalized
More than 2,000 lawsuits are now targeting the makers of Ozempic and Zepbound, with patients claiming the drugs caused dangerous and sometimes permanent health problems. The cases, consolidated in ...
Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.
Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...
GoodRx will sell Wegovy and Ozempic at US$499 monthly to eligible self-paying patients. Read more at straitstimes.com. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results